Neurotechnology for delaying dementia in patients with mild cognitive impairment

The main objective of this project is to establish a new standard for the treatment of mild cognitive impairment that will improve patients' quality of life and delay the onset of dementia. This treatment must also be accessible to a high percentage of patients.
The three general objectives of the project are:

1) Develop a technological solution that allows for the treatment of mild cognitive impairment for use at home and independently.

2) Conduct a clinical trial to evaluate the effectiveness of the solution in patients with mild cognitive impairment, as well as conduct a pilot study to analyze the appropriate implementation of the treatment in a real-world context of use.

3) Launch a one-year longitudinal study to evaluate the effectiveness of the solution in delaying the onset of dementia (mostly Alzheimer's).